» Articles » PMID: 22162252

In Vitro Three-dimensional (3D) Models in Cancer Research: an Update

Overview
Journal Mol Carcinog
Date 2011 Dec 14
PMID 22162252
Citations 133
Authors
Affiliations
Soon will be listed here.
Abstract

Tissues are three-dimensional (3D) entities as is the tumor that arises within them. Though disaggregated cancerous tissues have produced numerous cell lines for basic and applied research, it is generally agreed that these lines are poor models of in vivo phenomena. In this review we focus on in vitro 3D models used in cancer research, particularly their contribution to molecular studies of the early stages of metastasis, angiogenesis, the tumor microenvironment, and cancer stem cells. We present a summary of the various formats used in the field of tissue bioengineering as they apply to mechanistic modeling of cancer stages or processes. In addition we list studies that model specific types of malignancies, highlight drastic differences in results between 3D in vitro models and classical monolayer culturing techniques, and establish the need for standardization of 3D models for meaningful preclinical and therapeutic testing.

Citing Articles

Prospects and challenges of ovarian cancer organoids in chemotherapy research (Review).

Zhang W, Ding Y, He H, Chen K, Zeng Q, Cao X Oncol Lett. 2025; 29(4):198.

PMID: 40052067 PMC: 11883337. DOI: 10.3892/ol.2025.14944.


Advancing Radiobiology: Investigating the Effects of Photon, Proton, and Carbon-Ion Irradiation on PANC-1 Cells in 2D and 3D Tumor Models.

Charalampopoulou A, Barcellini A, Magro G, Bellini A, Borgna S, Fulgini G Curr Oncol. 2025; 32(1.

PMID: 39851965 PMC: 11763791. DOI: 10.3390/curroncol32010049.


Vascularized tumor on a microfluidic chip to study mechanisms promoting tumor neovascularization and vascular targeted therapies.

Skubal M, Larney B, Phung N, Desmaras J, Dozic A, Volpe A Theranostics. 2025; 15(3):766-783.

PMID: 39776800 PMC: 11700857. DOI: 10.7150/thno.95334.


A Novel Substituted Benzo[]quinoxaline-Based Cyclometalated Ru(II) Complex as a Biocompatible Membrane-Targeted PDT Colon Cancer Stem Cell Agent.

Marco A, Kasparkova J, Bautista D, Kostrhunova H, Cutillas N, Markova L J Med Chem. 2024; 67(23):21470-21485.

PMID: 39620973 PMC: 11647881. DOI: 10.1021/acs.jmedchem.4c02357.


Active fraction of ground cherry ( L.) calyces attenuates azoxymethane dextran sulfate sodium‑induced colon carcinogenesis in mice.

Ocampo Y, Caro D, Rivera D, Castro J, Pajaro I, Salas R Biomed Rep. 2024; 21(6):188.

PMID: 39420920 PMC: 11484217. DOI: 10.3892/br.2024.1876.